FDA approves first daily pill to drastically lower cholesterol levels

Federal regulators approved a first-of-its-kind cholesterol medication from Merck that rivals the effectiveness of powerful drugs already on the market.

The Food and Drug Administration (FDA) greenlit the once-daily pill called Lipfendra.

Lipfendra reduces “bad,” or low-density lipoprotein cholesterol (LDL-C) in adults by inhibiting the production of PCSK9 proteins.

Lipfendra is the first drug that...